Screener
Cardiff Oncology CRDF Q2 2025 earnings
Reported July 29, 2025 · Before market open
Revenue$121.0KBeat by $11.6K
EPS-$0.21Miss by $0.02
Revenue estimate$109.4K
EPS estimate-$0.19
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$67.2K
EPS estimate-$0.15
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Cardiff Oncology report Q2 2025 earnings?
- Cardiff Oncology (CRDF) reported Q2 2025 earnings on July 29, 2025 before market open.
- What were Cardiff Oncology's Q2 2025 revenue and EPS?
- Cardiff Oncology reported revenue of $121.0K and eps of $-0.21 for Q2 2025.
- Did Cardiff Oncology beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $109.4K by $11.6K. EPS missed the consensus estimate of $-0.19 by $0.02.
- How did Cardiff Oncology's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 25.8% from $163.0K a year earlier and eps grew 19.2% from $-0.26.
- Where can I find Cardiff Oncology's Q2 2025 SEC filings?
- You can read the 8-K earnings release (0000950170-25-099631) and the 10-Q periodic report (0000950170-25-099610) directly on SEC EDGAR. The filing index links above go to sec.gov.
